Periodic Reporting for period 1 - O-POINTED (Osteoarthritis patient cohorts in the dish - personalised cellular drug development tools for osteoarthritis precision medicine)

Pharma companies, biotechs and research institutes invest billions of Euros developing drugs for the growing osteoarthritis patient population. Still, they have failed to bring a drug to the market that would slow disease progression. This is because osteoarthritis is a...